We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$3.54B
AUM Growth
+$144M
Cap. Flow
-$130M
Cap. Flow %
-3.68%
Top 10 Hldgs %
8.2%
Holding
661
New
56
Increased
151
Reduced
396
Closed
49

Sector Composition

Rank Sector Weight
1 Financials 22.46%
2 Industrials 17.33%
3 Healthcare 11.34%
4 Technology 10.75%
5 Real Estate 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKO icon
426
ARKO Corp
ARKO
$495M
$1.77M 0.05%
204,192
-30
-0% -$278
AAON icon
427
Aaon
AAON
$7.03B
$1.77M 0.05%
35,213
+16,875
+92% +$787K
RETA
428
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.73M 0.05%
45,626
-27,424
-38% -$944K
INVE icon
429
Identive
INVE
$62.4M
$1.72M 0.05%
237,882
-85
-0% -$824
GHM icon
430
Graham Corp
GHM
$1.28B
$1.72M 0.05%
178,695
-226
-0.1% -$2.09K
ATRC icon
431
AtriCure
ATRC
$2.18B
$1.72M 0.05%
38,652
-2,210
-5% -$92.3K
ESTC icon
432
Elastic
ESTC
$7.94B
$1.67M 0.05%
32,356
+138
+0.4% +$8.27K
YELL
433
DELISTED
Yellow Corporation Common Stock
YELL
$1.66M 0.05%
659,459
-40,054
-6% -$143K
FFWM
434
DELISTED
First Foundation Inc
FFWM
$1.65M 0.05%
114,842
-149,006
-56% -$2.31M
IMGO
435
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$1.64M 0.05%
45,756
-625
-1% -$15.6K
SCPH
436
DELISTED
scPharmaceuticals
SCPH
$1.62M 0.05%
+226,604
New +$1.38M
HEES
437
DELISTED
H&E Equipment Services
HEES
$1.61M 0.05%
35,535
-104,695
-75% -$4.06M
CHRS icon
438
Coherus Oncology
CHRS
$187M
$1.6M 0.05%
202,506
-30
-0% -$231
IBEX icon
439
IBEX
IBEX
$491M
$1.6M 0.05%
64,406
-58
-0.1% -$1.31K
RXO icon
440
RXO
RXO
$3.54B
$1.56M 0.04%
+90,719
New +$1.61M
CIO
441
DELISTED
City Office REIT
CIO
$1.56M 0.04%
185,639
-296,427
-61% -$2.85M
BHR
442
Braemar Hotels & Resorts
BHR
$138M
$1.55M 0.04%
376,085
-55
-0% -$226
PVBC
443
DELISTED
Provident Bancorp
PVBC
$1.48M 0.04%
203,590
-94,558
-32% -$960K
QDEL icon
444
QuidelOrtho
QDEL
$959M
$1.42M 0.04%
+16,608
New +$1.41M
MNTX
445
DELISTED
Manitex International, Inc.
MNTX
$1.41M 0.04%
352,510
-19,464
-5% -$90K
EVH icon
446
Evolent Health
EVH
$464M
$1.4M 0.04%
49,882
+24,162
+94% +$693K
PLAB icon
447
Photronics
PLAB
$1.95B
$1.38M 0.04%
82,115
-78,628
-49% -$1.34M
BMTX
448
DELISTED
BM Technologies, Inc.
BMTX
$1.38M 0.04%
265,050
-134,315
-34% -$857K
COGT icon
449
Cogent Biosciences
COGT
$6.61B
$1.38M 0.04%
119,165
-1,883
-2% -$23.3K
VSEC icon
450
VSE Corp
VSEC
$6.79B
$1.37M 0.04%
29,164
-6
-0% -$273

Similar funds

Kennedy Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Kennedy Capital Management held 661 positions worth $3.54B, up 4.2% from $3.4B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Kennedy Capital Management withdrew a net $130M in Q4 2022, closing 49 positions and reducing 396 holdings. Its most notable exit was Switch, Inc. Class A Common Stock, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in WESCO International worth $9.66M.

  • Kennedy Capital Management's largest Q4 2022 buy was WESCO International: 77,177 shares worth $9.66M.
  • Kennedy Capital Management added most to SouthState Bank Corp in Q4 2022, an estimated $13.9M increase.
  • Kennedy Capital Management's biggest Q4 2022 reduction was Adeia, cutting an estimated $10.3M.
  • Kennedy Capital Management fully exited Switch, Inc. Class A Common Stock in Q4 2022, selling an estimated $20.1M.
  • Kennedy Capital Management's ten largest holdings make up 8.2% of its $3.54B portfolio in Q4 2022.
  • Kennedy Capital Management opened 56 new positions and closed 49 in Q4 2022.
  • Kennedy Capital Management's portfolio value rose 4.2% quarter-over-quarter to $3.54B.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.